A glucose-insulin-potassium infusion did not reduce mortality, cardiac arrest, or cardiogenic shock after acute MI

Berger, Peter B.
July 2005
ACP Journal Club;Jul/Aug2005, Vol. 143 Issue 1, p14
Academic Journal
This article presents information on a study related to effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. In patients with acute myocardial infarction (MI), an infusion of glucose-insulin-potassium in addition to usual care did not reduce mortality, cardiac arrest, or cardiogenic shock. In the first GUSTO trial, no benefit was seen from intravenous heparin compared with subcutaneous unfractionated heparin in patients receiving streptokinase for ST-elevation MI.


Related Articles

  • Clinical Profile and Mortality of ST-Segment Elevation Myocardial Infarction Patients Receiving Thrombolytic Therapy in the Middle East. Panduranga, Prashanth; Al-Zakwani, Ibrahim; Sulaiman, Kadhim; Al-Habib, Khalid; Al Suwaidi, Jassim; Al-Motarreb, Ahmed; Alsheikh-Ali, Alawi; Al Saif, Shukri; Al Faleh, Hussam; Almahmeed, Wael; Asaad, Nidal; Amin, Haitham; Al-Lawati, Jawad; Hersi, Ahmad // Heart Views;Apr-Jun2012, Vol. 13 Issue 2, p35 

    Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in hospital within 12 hours from pain onset...

  • DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93 

    The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...

  • Diabetes is an independent predictor of survival 17 years after myocardial infarction: follow-up of the TRACE registry. Kümler, Thomas; Gislason, Gunnar H.; Køber, Lars; Torp-Pedersen, Christian // Cardiovascular Diabetology;2010, Vol. 9, p22 

    Background: In patients hospitalized for myocardial infarction, there are limited data examining the long-term prognostic effect of diabetes. The aim of this study was to systematically evaluate the development of diabetes as an independent long-term prognostic factor after myocardial...

  • Predictive Value of NSVT in Non-ST Elevation Acute Coronary Syndromes. DiMarco, John P. // Clinical Cardiology Alert;Oct2010, Vol. 29 Issue 10, p76 

    MERLIN-TIMI 36 TESTED THE HYPOTHESIS THAT RANOLAZINE, a recently approved anti-anginal agent, would benefit patients with non-ST-elevation acute coronary syndrome (NSTEACS). Favorable trends that did not reach statistical significance were noted in the main study report (Circulation....

  • Oscillatory functions affecting outcome of coronary heart disease: The hazard of too much or too... Wolf, Stewart // Integrative Physiological & Behavioral Science;Apr-Jun95, Vol. 30 Issue 2, p118 

    Identifies the physiological and behavioral indicators predictive of sudden arrhythmic death in patients who had experienced myocardial infarction in the past. Non-determinants of cardiac mortality; Degree of instability required in the proper physiological balance.

  • Mortality risk higher for MI patients who receive blood transfusions.  // Cardiology Today;Feb2013, Vol. 16 Issue 2, p21 

    The article discusses a study published in the "Archives of Internal Medicine," which found a higher mortality risk among patients with myocardial infarction (MI) who receive blood transfusions.

  • Always look on the bright side…. McCrory, P. // British Journal of Sports Medicine;Feb2007, Vol. 41 Issue 2, p63 

    The author reflects on the increasing number cardiovascular mortality in sports. According to the author, several studies have demonstrated increased cardiovascular mortality with the outcome of local and national football teams. He pointed that mostly is male mortality from myocardial...

  • Serum Chelatable Redox-Active Iron Is an Independent Predictor of Mortality After Myocardial Infarction in Individuals With Diabetes. Sulieman, Mahmoud; Asleh, Rabea; Cabantchik, Zvi I.; Breuer, William; Aronson, Doron; Suleiman, Abeer; Miller-Lotan, Rachel; Hammerman, Haim; Levy, Andrew P. // Diabetes Care;Nov2004, Vol. 27 Issue 11, p2730 

    Presents a study which examined the association of labile plasma iron (LPI) with myocardial infarction and mortality in individuals with diabetes. Blood collection and measurement of LIP; Research design and methodology; Results and discussion; Conclusions.

  • Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study. Bertomeu, Antonia; García-Vidal, Olga; Farré, Xavier; Galobart, Albert; Vàzquez, Manuel; Laguna, Juan Carlos; Ros, Emilio // BMJ: British Medical Journal (International Edition);9/13/2003, Vol. 327 Issue 7415, p591 

    Presents a cross sectional autopsy study on preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction. Indications that atherosclerosis begins in childhood; Participants; Methods; Results; Comment; Conclusion that morbidity and mortality from myocardial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics